265 related articles for article (PubMed ID: 23875042)
1. Cathelicidin-like helminth defence molecules (HDMs): absence of cytotoxic, anti-microbial and anti-protozoan activities imply a specific adaptation to immune modulation.
Thivierge K; Cotton S; Schaefer DA; Riggs MW; To J; Lund ME; Robinson MW; Dalton JP; Donnelly SM
PLoS Negl Trop Dis; 2013; 7(7):e2307. PubMed ID: 23875042
[TBL] [Abstract][Full Text] [Related]
2. A parasitic helminth-derived peptide that targets the macrophage lysosome is a novel therapeutic option for autoimmune disease.
Alvarado R; O'Brien B; Tanaka A; Dalton JP; Donnelly S
Immunobiology; 2015 Feb; 220(2):262-9. PubMed ID: 25466586
[TBL] [Abstract][Full Text] [Related]
3. A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides.
Robinson MW; Donnelly S; Hutchinson AT; To J; Taylor NL; Norton RS; Perugini MA; Dalton JP
PLoS Pathog; 2011 May; 7(5):e1002042. PubMed ID: 21589904
[TBL] [Abstract][Full Text] [Related]
4. A helminth cathelicidin-like protein suppresses antigen processing and presentation in macrophages via inhibition of lysosomal vATPase.
Robinson MW; Alvarado R; To J; Hutchinson AT; Dowdell SN; Lund M; Turnbull L; Whitchurch CB; O'Brien BA; Dalton JP; Donnelly S
FASEB J; 2012 Nov; 26(11):4614-27. PubMed ID: 22872675
[TBL] [Abstract][Full Text] [Related]
5. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.
Donnelly S; Stack CM; O'Neill SM; Sayed AA; Williams DL; Dalton JP
FASEB J; 2008 Nov; 22(11):4022-32. PubMed ID: 18708590
[TBL] [Abstract][Full Text] [Related]
6.
Ryan S; Shiels J; Taggart CC; Dalton JP; Weldon S
Front Immunol; 2020; 11():2182. PubMed ID: 32983184
[TBL] [Abstract][Full Text] [Related]
7. Schistosoma mansoni immunomodulatory molecule Sm16/SPO-1/SmSLP is a member of the trematode-specific helminth defence molecules (HDMs).
Shiels J; Cwiklinski K; Alvarado R; Thivierge K; Cotton S; Gonzales Santana B; To J; Donnelly S; Taggart CC; Weldon S; Dalton JP
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008470. PubMed ID: 32644998
[TBL] [Abstract][Full Text] [Related]
8. Cationic host defence peptides: multifaceted role in immune modulation and inflammation.
Choi KY; Chow LN; Mookherjee N
J Innate Immun; 2012; 4(4):361-70. PubMed ID: 22739631
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional cationic host defence peptides and their clinical applications.
Yeung AT; Gellatly SL; Hancock RE
Cell Mol Life Sci; 2011 Jul; 68(13):2161-76. PubMed ID: 21573784
[TBL] [Abstract][Full Text] [Related]
10. The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages.
Alvarado R; To J; Lund ME; Pinar A; Mansell A; Robinson MW; O'Brien BA; Dalton JP; Donnelly S
FASEB J; 2017 Jan; 31(1):85-95. PubMed ID: 27682204
[TBL] [Abstract][Full Text] [Related]
11. The immunology of host defence peptides: beyond antimicrobial activity.
Hancock RE; Haney EF; Gill EE
Nat Rev Immunol; 2016 May; 16(5):321-34. PubMed ID: 27087664
[TBL] [Abstract][Full Text] [Related]
12. As-CATH1-6, novel cathelicidins with potent antimicrobial and immunomodulatory properties from
Chen Y; Cai S; Qiao X; Wu M; Guo Z; Wang R; Kuang YQ; Yu H; Wang Y
Biochem J; 2017 Aug; 474(16):2861-2885. PubMed ID: 28798159
[TBL] [Abstract][Full Text] [Related]
13. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
14. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
Tendler M; Brito CA; Vilar MM; Serra-Freire N; Diogo CM; Almeida MS; Delbem AC; Da Silva JF; Savino W; Garratt RC; Katz N; Simpson AS
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):269-73. PubMed ID: 8552619
[TBL] [Abstract][Full Text] [Related]
15. Porcine host defense peptides: expanding repertoire and functions.
Sang Y; Blecha F
Dev Comp Immunol; 2009 Mar; 33(3):334-43. PubMed ID: 18579204
[TBL] [Abstract][Full Text] [Related]
16. Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide.
Bommineni YR; Pham GH; Sunkara LT; Achanta M; Zhang G
Mol Immunol; 2014 May; 59(1):55-63. PubMed ID: 24491488
[TBL] [Abstract][Full Text] [Related]
17. Secreted products of Fasciola hepatica inhibit the induction of T cell responses that mediate allergy.
Finlay CM; Stefanska AM; Coleman MM; Jahns H; Cassidy JP; McLoughlin RM; Mills KHG
Parasite Immunol; 2017 Oct; 39(10):. PubMed ID: 28815724
[TBL] [Abstract][Full Text] [Related]
18. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase.
Hillyer GV; Soler de Galanes M; Battisti G
Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.
Dalton JP; Robinson MW; Mulcahy G; O'Neill SM; Donnelly S
Vet Parasitol; 2013 Aug; 195(3-4):272-85. PubMed ID: 23623183
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14.
Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M
Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
